Please assess the completion status of the following clinical trial:

Trial Title: Effect of TF-TAVR on Emotional Status, Quality of Life, Frailty and Inflammation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic aortic valve stenosis~* Planned elective transcatheter aortic valve replacement~* Willingness and ability to provide signed informed consent (IC) form prior to participation in any study-related procedures~Exclusion Criteria:~* Disease reducing life expectancy to \< 1 year~* Severe immune-system modulating or -affecting disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).